Latest Fresenius Stories

2013-01-25 23:00:26

Fresenius Medical Care is a large provider of dialysis services and dialysis products, such as Granuflo and NaturaLyte. d'Oliveira & Associates released a new webpage on Fresenius lawsuits (PRWEB) January 25, 2013 NaturaLyte comes as a liquid acid concentrate and dry pack concentrate used in dialysis. According to the New York Times on November 4, 2011, Fresenius issued an internal memo to doctors and dialysis service providers warning that its dialysis products had been linked to an...

2012-10-11 04:01:52

Reich & Binstock, LLP is currently investigating claims against Fresenius Medical Care AG, the makers of dialysis products GranuFlo® and NaturaLyte®. These products have been linked to causing alkalosis, a condition associated with an increase in cardiovascular death and catastrophic cardiovascular injuries in patients undergoing dialysis. Houston, Texas (PRWEB) October 10, 2012 Reich & Binstock, LLP, a Houston-based law firm, is currently investigating claims against...

2012-10-03 23:01:38

Per the FDA, Fresenius Medical Care failed to notify its entire client base of its product´s adverse side effects Cleveland, OH (PRWEB) October 03, 2012 Cleveland, Ohio, law firm Spangenberg Shibley & Liber is now investigating claims on behalf of individuals who allegedly suffered heart problems, cardiac arrest, or death while undergoing kidney dialysis using Fresenius Medical Care´s GranuFlo or NaturaLyte products. fda.gov/MedicalDevices/Safety/ListofRecalls/ucm309990.htm...

2008-09-10 18:00:34

APP Pharmaceuticals, Inc., formerly traded on the NASDAQ Capital Market under the symbol APPX, today announced that the NASDAQ Global Market has accepted for listing the Contingent Value Rights (CVRs) related to the acquisition of APP by Fresenius Kabi, a business segment of Fresenius SE. The CVRs will trade under the symbol "APCVZ" beginning on Thursday, September 11, 2008. The acquisition of APP was completed earlier today. On July 7, 2008, Fresenius announced the agreement to acquire...

2008-09-10 12:00:51

APP Pharmaceuticals, Inc., formerly traded on the NASDAQ Capital Market under the symbol APPX, today announced that Fresenius Kabi, a business segment of Fresenius SE, has completed its acquisition of APP. The official close date is September 10, 2008. Fresenius Kabi has stated that the acquisition is an important step in its growth strategy. Through APP, Fresenius Kabi enters the U.S. pharmaceuticals market and achieves a leading position in the global I.V. generics industry. Dr....

2008-07-07 03:00:34

APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading provider of hospital-based injectable pharmaceutical products, and Fresenius SE (XETRA:FRE), a global health care group with approximately $18 billion of sales in products and services for hospital, dialysis and in home medical care, today announced that they have entered into a definitive merger agreement pursuant to which Fresenius will acquire APP. Under the terms of the agreement, Fresenius will acquire the outstanding common stock...

Word of the Day
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.